Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects

Background There are no studies that relate BsmI polymorphism of the vitamin D receptor (VDR) gene and with vitamin D to blood pressure (BP). Objective To analyze if this polymorphism and 25-hydroxyvitamin D levels (25OHD3) influence BP in a population of healthy subjects. Design Transversal study on healthy population. Stepwise multiple regression analysis was performed to assess the association of BP with several clinical and biochemical data. Setting Industrial employees, blood donors, and army cadets from Lleida, Spain were recruited in October 2001. Individuals A total of 590 apparently healthy subjects (260 males and 330 females). Measurements Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were determined as the mean of three measurements. We also included age, gender, body mass index (BMI), serum levels of creatinine, calcium, phosphorus, intact parathyroid hormone (by two-site chemiluminometric assay), 25-hydroxyvitamin D (by radioimmunoassay) and BsmI genotype. Results Since gender was strongly associated with both SBP and DBP, a separate analysis was performed for men and women. In males, SBP was associated with BMI, 25OHD3 (β: 0.37, P < 0.000) and genotype (β: –4.1, P < 0.001); and DBP with 25OHD3 (β: 0.19, P < 0.008) and age. SBP was higher in men with bb genotype than in the other genotypes (P < 0.006). Moreover, there was a statistically significant positive correlation between 25OHD3 and both SBP (r: 0.53, P < 0.002) and DBP (r: 0.48, P < 0.005) in men with genotype BB. In women, neither 25OHD3 nor genotype were associated with BP levels. Conclusions BsmI polymorphism of the VDR gene influences BP in healthy men. A positive relationship between serum 25-hydroxyvitamin D levels and BP is present only in men with the BB genotype.

[1]  S. Kato,et al.  Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. , 2003, The Journal of nutrition.

[2]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[3]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[4]  D. Levy,et al.  Impact of high-normal blood pressure on the risk of cardiovascular disease. , 2002, The New England journal of medicine.

[5]  D. Levy,et al.  Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease , 2001 .

[6]  R. Saracho,et al.  Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients. , 1999, Kidney international.

[7]  D. Bell,et al.  Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. Montoliu,et al.  Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. , 1997, Journal of the American Society of Nephrology : JASN.

[9]  L. Curtin,et al.  Dietary calcium, alcohol, and incidence of treated hypertension in the NHANES I epidemiologic follow-up study. , 1996, American journal of epidemiology.

[10]  J. Mohler,et al.  Association of prostate cancer with vitamin D receptor gene polymorphism. , 1996, Cancer research.

[11]  B. Dawson-Hughes,et al.  Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. , 1995, The Journal of clinical endocrinology and metabolism.

[12]  J. Rastad,et al.  Vitamin D receptor genotypes in primary hyperparathyroidism , 1995, Nature Medicine.

[13]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[14]  J. Li,et al.  Effect of long-term administration of 1,25 (OH)2 vitamin D3 on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. , 1993, American journal of hypertension.

[15]  R. Bukoski,et al.  On the vascular inotropic action of 1,25-(OH)2 vitamin D3. , 1993, American journal of hypertension.

[16]  R. Bukoski,et al.  Injection of 1,25-(OH)2 vitamin D3 enhances resistance artery contractile properties. , 1990, Hypertension.

[17]  M. Haussler,et al.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. , 1989, The Journal of clinical investigation.

[18]  R. Wallace,et al.  Relationship between 1,25-dihydroxyvitamin D and blood pressure in a geographically defined population. , 1988, The American journal of clinical nutrition.

[19]  H. Kawashima,et al.  1,25-Dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aorta. , 1988, Biochemical and biophysical research communications.

[20]  N. Henningsen,et al.  CALCIUM AND BLOOD PRESSURE , 1986, The Lancet.

[21]  R. Rill,et al.  Ultrasensitive staining of nucleic acids with silver. , 1982, Analytical biochemistry.

[22]  R. Rubin,et al.  Enhanced Parathyroid Function in Essential Hypertension A Homeostatic Response to a Urinary Calcium Leak , 1980, Hypertension.

[23]  M. Nusynowitz,et al.  THYROTOXICOSIS DUE TO " SILENT " THYROIDITIS , 1975, The Lancet.

[24]  L. Serra Majem,et al.  [Distribution of the serum concentration of vitamin C, folic acid and vitamin B12 in a representative sample of the adult population of Catalonia (Spain)]. , 2002, Medicina clínica (Ed. impresa).

[25]  K. Ishibashi,et al.  1,25(OH)2D3 modulates intracellular Ca2+ and force generation in resistance arteries. , 1996, The American journal of physiology.